Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia
NCT00136799
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
325
Enrollment
INDUSTRY
Sponsor class
Conditions
Mixed Dyslipidemia
Hypercholesterolemia
Interventions
DRUG:
Fluvastatin
Sponsor
Novartis